,for, Item ID-
  • #1235491
  • Providers like you icon
  • Sanofi Pasteur #49281057415

BEYFORTUS™ Nirsevimab-alip 100 mg / mL Injection 0.5 mL

BEYFORTUS, PFS 100MG/ML (5/BX)

Features

  • BEYFORTUS is a respiratory syncytial virus (RSV) F protein‑directed fusion inhibitor indicated for the prevention of RSV lower respiratory tract disease
  • BEYFORTUS is an antibody that contains nirsevimab-alip which is used to help prevent RSV disease for 5 months
  • Indicated for Newborns and babies under 1 year of age born during or entering their first RSV season, and children up to 24 months of age who remain at risk of severe RSV disease through their second RSV season
  • More …
  Log In to Order
or

Product Specifications


Features
  • BEYFORTUS is a respiratory syncytial virus (RSV) F protein‑directed fusion inhibitor indicated for the prevention of RSV lower respiratory tract disease
  • BEYFORTUS is an antibody that contains nirsevimab-alip which is used to help prevent RSV disease for 5 months
  • Indicated for Newborns and babies under 1 year of age born during or entering their first RSV season, and children up to 24 months of age who remain at risk of severe RSV disease through their second RSV season
  • For Intramuscular Injection Only

Professionals Also Viewed